abstract |
The present invention provides a device for internal use, comprising an implant or temporary device and at least one source of the orilliomas compound or derivative thereof. The present invention also provides a method for inhibiting cell growth by topically administering a therapeutically effective amount of the Myolimus compound, or a derivative thereof. In addition, the present invention also includes a method of treating an eye disease or condition by administering a therapeutically effective amount of the Myolimus compound, or a derivative thereof. |